Nailton José Neto

Nailton José Neto

Auto-generated profile, based on publicly available information

Nailton José Neto

Graduate Program in Health Sciences, Federal University of Rio Grande do Norte, Natal, Brazil

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
NNNailton José Neto
Nailton José Neto
MBMário Duarte Brito
Mário Duarte Brito
CGCristiano Dos Santos Gomes
Cristiano Dos Santos Gomes
LCLuana Caroline de Assunção Cortez Corrêa
Luana Caroline de Assunção Cortez Corrêa
GGGerlane Coelho Bernardo Guerra
Gerlane Coelho Bernardo Guerra
Ricardo GuerraRicardo Guerra
Ricardo Guerra
Introduction: Sarcopenia and Osteoporosis are two prevalent conditions in the older population and are defined by low strength, muscle quality/volume and low Bone Mineral Density, respectively. When there is a concomitant presence of both, there is a novel musculoskeletal condition called Osteosarcopenia. These conditions adversely affect quality of life and elevate the risk of fractures, disability, and mortality among older individuals. Dysbiosis of the gut microbiota is the impairment of the mutualistic relationship between microorganisms, metabolic products and the host’s immune system. Gut microbiota dysbiosis could be intricately linked to sarcopenia and osteoporosis, shedding light on the complex microbiota-gut-bone-muscle axis. Furthermore, the intestinal microbiota experiences a notable decline in beneficial microorganisms as part of the aging process. The relationship between dysbiosis of the intestinal microbiota in older people and sarcopenia, osteoporosis or osteosarcopenia is still unclear. This review protocol aims to systematically review the literature and compile evidence on the influence of gut microbiota dysbiosis on musculoskeletal function in older people with sarcopenia, osteoporosis or osteosarcopenia. Methods/Analysis: This systematic review will analyze observational studies that have investigated the relationship between the effects of gut microbiota dysbiosis and sarcopenia, osteoporosis and osteosarcopenia in older people aged 65 and over. Studies will be retrieved from PubMed/MEDLINE, EMBASE, Scopus, Web of Science and the Cochrane Library. Outcome measures will include body composition for diagnosing osteoporosis and screening for sarcopenia/osteosarcopenia by any criteria. Data synthesis will involve quantitative analysis using summary measures. If sufficient studies, homogeneity and heterogeneity analysis will be performed to conduct Meta-analysis and pooled OR, RR and HR measures will be provided.

16 April 2026 in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
Verified
Journal Article
Open access
PDF file
NNNailton José Neto
Nailton José Neto
GHGuy Hajj-Boutros
Guy Hajj-Boutros
WCWayne Lok Ok Choo
Wayne Lok Ok Choo
MBMiguel G. Borda
Miguel G. Borda
KPKonstantinos Prokopidis
Konstantinos Prokopidis
Gustavo DuqueGustavo Duque
Gustavo Duque
Intrinsic capacity (IC) is defined as the composite of physical and mental abilities an individual possesses, encompassing 5 domains: cognition, psychological health, sensory function, vitality, and locomotion. This construct is central to the World Health Organization’s framework for assessing functional ability in older adults. Growing evidence highlights the critical role of the musculoskeletal system in maintaining these domains, while conditions such as sarcopenia, osteoporosis, and their coexistence as osteosarcopenia (OS) are increasingly associated with IC decline. This narrative review compiles current evidence on the modulatory role of muscles and bones in IC and the impacts of sarcopenia, osteoporosis, and OS. Most findings suggest that musculoskeletal tissues influence IC not only through biomechanical functions but also as secretory organs, releasing myokines and osteokines with endocrine, paracrine, and autocrine effects. Among the most studied are brain-derived neurotrophic factor, irisin, osteocalcin, and interleukin-6. Dysregulation of these pathways, along with biomechanical dysfunction and systemic inflammation, links sarcopenia, osteoporosis, and OS to IC impairment. Further research is needed to clarify the specific mechanisms involved, particularly in the sensory and vitality domains, to inform targeted interventions that promote healthy aging.

24 September 2022 in Archives of Gerontology and Geriatrics
Verified
Journal Article
Closed access
NNNailton José Neto
Nailton José Neto
CGCristiano dos Santos Gomes
Cristiano dos Santos Gomes
ASAna Carolina Patricio de Albuquerque Sousa
Ana Carolina Patricio de Albuquerque Sousa
JFJuliana Fernandes
Juliana Fernandes
TATamer Ibrahim Salah Ahmed
Tamer Ibrahim Salah Ahmed
Ricardo GuerraRicardo Guerra
Ricardo Guerra

22 November 2023 in European Geriatric Medicine
Verified
Journal Article
Closed access
PDF file
EJEdmilson Gomes da Silva Júnior
Edmilson Gomes da Silva Júnior
CGCRISTIANO DOS SANTOS Gomes
CRISTIANO DOS SANTOS Gomes
NNNailton José Neto
Nailton José Neto
JFJuliana Fernandes
Juliana Fernandes
CCCarmen-Lucia Curcio
Carmen-Lucia Curcio
Ricardo GuerraRicardo Guerra
Ricardo Guerra

18 July 2025 in BMJ Open
Verified
Journal Article
Open access
PDF file
MBMário Duarte Brito
Mário Duarte Brito
NNNailton José Neto
Nailton José Neto
CGCristiano dos Santos Gomes
Cristiano dos Santos Gomes
Weslley Barbosa SalesWeslley Barbosa Sales
Weslley Barbosa Sales
GGGerlane Coelho Bernardo Guerra
Gerlane Coelho Bernardo Guerra
Ricardo GuerraRicardo Guerra
Ricardo Guerra
Introduction Sarcopenia, osteoporosis and osteosarcopenia are conditions prevalent in ageing that impair muscle strength and bone density, increasing the risks of fractures, falls, disability and mortality. Recent studies highlight the benefits of milk protein supplementation (MPS) combined with exercises to improve musculoskeletal health in the older population. This systematic review protocol will enable the production of a compilation of evidence that will elucidate the effects of MPS combined with aerobic exercise, resistance exercise or both on the musculoskeletal function of older individuals with these three conditions. Methods/analysis Studies will be selected from electronic databases, including PubMed/MEDLINE, EMBASE, Scopus, Web of Science and the Cochrane Library, without restrictions on language or publication date. The outcomes evaluated will include muscle mass, muscle strength, BMD and physical performance after combined interventions of MPS and physical exercise of any type. The risk of bias will be assessed using the Cochrane Risk of Bias 2 tool. The Grading of Recommendations Assessment, Development and Evaluation approach will be used to classify the certainty of the evidence into four levels: high, moderate, low and very low. Meta-analysis will be performed given the homogeneity of the studies, using random effects methods in the face of the expected heterogeneity. The standardised mean difference (SMD) will be used for continuous data, and the I² index will assess heterogeneity (I² > 50%). Sensitivity analysis, ‘leave one out’ and a strategy for dealing with missing data will be carried out. Statistical analysis will be conducted using the STATA 18 software with a 95% CI and p<0.05. The searches will be carried out from inception until August 2025. Ethics and dissemination Formal ethical approval will not be required as primary data collection will not be performed. The results will be disseminated through peer-reviewed publications and presentations at conferences dedicated to the relevant field of study. PROSPERO registration number CRD42024555933.

7 April 2026 in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
Verified
Journal Article
Open access
IBIvan Baltasar-Fernandez
Ivan Baltasar-Fernandez
Pedro L. ValenzuelaPedro L. Valenzuela
Pedro L. Valenzuela
IRIrene Rodríguez-Gómez
Irene Rodríguez-Gómez
FQFabio Quiñonez-Bareiro
Fabio Quiñonez-Bareiro
Luis M. AlegreLuis M. Alegre
Luis M. Alegre
FGFrancisco José JOSÉ GARCÍA García-García
Francisco José JOSÉ GARCÍA García-García
Background: Osteosarcopenia—the coexistence of osteopenia/osteoporosis and sarcopenia—is associated with numerous adverse health outcomes, but its association with intrinsic capacity (IC) remains unknown. We aimed to explore the associations of osteosarcopenia with IC and all-cause mortality in older adults. Methods: We conducted a cross-sectional analysis of IC and a prospective analysis of all-cause mortality in 1142 participants from the Toledo Study for Healthy Aging (75.1 ± 6.0 years, 53.1% women). Participants were classified as having no musculoskeletal disorders, osteopenia/osteoporosis, sarcopenia, or osteosarcopenia (DXA- and EWGSOP2-based criteria). IC was operationalized as a composite score integrating locomotion, cognition, psychological, vitality, and sensory domains. Results: Older adults with osteosarcopenia exhibited lower total IC (76.6 ± 1.1 points) than those without musculoskeletal disorders (83.7 ± 0.5 points; p < .001) or with osteopenia/osteoporosis (81.3 ± 0.3 points; p < .001), with significant differences also found between the latter groups (p < .001). Specifically, osteosarcopenia was associated with poorer results in the locomotion, cognition, vitality, and sensory domains (all p < .01), but not in the psychological domain. Over a median 6.2-year follow-up, osteosarcopenia—but not osteopenia/osteoporosis—was associated with a higher risk of mortality compared to those without musculoskeletal disorders [HR (95% CI)=1.96 (1.02-3.77); p = .045]. In joint analyses with IC status (high vs low, segregated by the median), this association was specifically observed among participants with osteosarcopenia and low IC [HR = 2.55 (1.31-4.96); p = .004]. Conclusions: Osteosarcopenia is associated with lower total IC and impairments across most IC domains. This finding is of clinical relevance, as the combination of this condition and low IC is associated with an increased mortality risk.